{"name":"BIOMILQ","slug":"biomilq","ticker":"Private","exchange":"Private","domain":"biomilq.com","description":"BIOMILQ is a private company focused on food technology and cell culture. They are developing a platform to produce human milk oligosaccharides (HMOs) through cell culture. This technology has the potential to revolutionize the infant nutrition industry. BIOMILQ is currently in the private phase and has not yet gone public, but it has received significant funding and attention from investors.","hq":"Durham, NC","founded":0,"employees":"","ceo":"Michelle Egger","sector":"Food Technology / Cell Culture","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"Private","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-15","type":"deal","headline":"BIOMILQ Raises $20 Million in Series A Funding","summary":"BIOMILQ has raised $20 million in Series A funding to support the development of its cell culture platform for producing HMOs.","drugName":"","sentiment":"positive"},{"date":"2023-09-01","type":"regulatory","headline":"BIOMILQ Receives FDA Clearance for its Cell Culture Facility","summary":"BIOMILQ has received FDA clearance for its cell culture facility, allowing the company to move forward with the production of HMOs.","drugName":"","sentiment":"positive"}],"realNews":[],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":2,"keyCompetitors":["Mannatech","Glanbia","Royal DSM"],"therapeuticFocus":["Infant Nutrition","Cell Culture"],"financials":null,"yahoo":null}